Abstract
A randomized placebo-controlled pre-clinical trial of the anti-angiogenic thromobspondin-mimetic peptide ABT-526 plus Lomustine chemotherapy versus Lomustine chemotherapy alone in pet dogs with relapsed non-Hodgkin's lymphoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have